Raanan Shenhav

Most boards optimize the quarter and miss the sequence. I%27m the one who tells you which of this year%27s rational decisions is the one you can%27t take back.

I%27m a venture strategist and the architect of the Compounder%27s Law framework. My work sits on a single idea: in path-dependent markets, the decision that kills you looks reasonable on the day you make it. The damage is in the order, not the average.
I read companies for the irreversible move, the vendor lock-in that becomes a sovereignty problem, the capability you%27re compounding that%27s quietly calcifying into your next constraint, the metric everyone trusts that%27s already lying to them.

I%27m most useful to companies making bets they can%27t unwind: deep tech, biotech, AI and compute infrastructure, anyone whose moat is being set in the next thirty-six months and won%27t be re-openable after. Post-Series-A through growth, where the strategy is real enough to have consequences and early enough to still change shape.

If your hardest question is %22are we building the right irreversible thing,%22 that%27s the room I belong in... I don%27t validate the plan. I stress-test the sequence.